AMIX — Autonomix Medical, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1617867 ·
Last close
$0.42
Market Cap
$4.77M
52W High
$0.47
52W Low
$0.20
ADV30
1,344,797
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -3,343,000 | -3,261,000 | 10,211,000 | 9,934,000 | 1,650,000 |
| Sep 2025 | 0 | — | -7,534,000 | -7,451,000 | 7,932,000 | 7,477,000 | 1,487,000 |
| Jun 2025 | 0 | — | -3,421,000 | -3,337,000 | 8,997,000 | 8,589,000 | 1,965,000 |
| Mar 2025 | 0 | — | -3,252,000 | -3,191,000 | 9,806,000 | 9,136,000 | 1,707,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,899,000
Investing CF
$-11,000
Financing CF
$10,021,000
CapEx
$-9,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-4.27
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-64,427,000
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-17,194,000
Pretax Income TTM
$-17,240,000
Interest Exp TTM
$46,000
Analysts
1
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -11,588,000 | -11,410,000 | 9,806,000 | 1,707,000 | — | -8,258,000 |
| Mar 2024 | 0 | -7,474,000 | -15,426,000 | 9,407,000 | 1,779,000 | — | -6,648,000 |
| Mar 2023 | 0 | -1,990,000 | -1,990,000 | 865,000 | 221,000 | — | -1,854,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-7.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NXGL | NEXGEL, INC. | $4.80M | $0.53 | — |
| DROR | Dror Ortho-Design, Inc. | $4.88M | $0.00 | — |
| ADMT | ADM TRONICS UNLIMITED, INC. | $5.41M | $0.08 | — |
| XAIR | Beyond Air, Inc. | $5.55M | $0.44 | — |
| BTCY | BIOTRICITY INC. | $4.07M | $0.14 | — |
News headlines (Yahoo Finance, 1h cache)
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
2026-05-19 12:30 · Yahoo
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
2026-05-18 12:45 · Yahoo
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
2026-04-29 12:45 · Yahoo
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026
2026-04-22 12:42 · Yahoo
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026
2026-04-08 12:40 · Yahoo
Autonomix Medical to Present at LSI USA ’26
2026-03-11 12:40 · Yahoo
Autonomix Medical Selected for Best Innovation Competition at CRT 2026
2026-03-05 13:45 · Yahoo
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
2026-03-04 13:40 · Yahoo
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation
2026-02-25 13:30 · Yahoo
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
2026-02-19 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.